{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:04:54Z","timestamp":1788930294055,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901712"],"award-info":[{"award-number":["81901712"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271981"],"award-info":[{"award-number":["82271981"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Science and Technology Program","award":["2021YFS0175"],"award-info":[{"award-number":["2021YFS0175"]}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2022NSFSC0735"],"award-info":[{"award-number":["2022NSFSC0735"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youth Innovation Research Project of Sichuan Medical Association","award":["Q21012"],"award-info":[{"award-number":["Q21012"]}]},{"DOI":"10.13039\/501100009812","name":"Chinese Society of Clinical Oncology","doi-asserted-by":"publisher","award":["HFCSC2019B01"],"award-info":[{"award-number":["HFCSC2019B01"]}],"id":[{"id":"10.13039\/501100009812","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Duchenne muscular dystrophy (DMD) is a fatal genetic muscle-wasting disease that affects 1 in 5000 male births with no current cure. Despite great progress has been made in the research of DMD, its underlying pathological mechanism based on the metabolomics is still worthy of further study. Therefore, it is necessary to gain a deeper understanding of the mechanisms or pathogenesis underlying DMD, which may reveal potential therapeutic targets and\/or biomarkers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Plasma samples from 42 patients with DMD from a natural history study and 40 age-matched healthy volunteers were subjected to a liquid chromatography-mass spectrometry-based non-targeted metabolomics approach. Acquired metabolic data were evaluated by principal component analysis, partial least squares-discriminant analysis, and metabolic pathway analysis to explore distinctive metabolic patterns in patients with DMD. Differentially expressed metabolites were identified using publicly available and integrated databases. By comparing the DMD and healthy control groups, 25 differential metabolites were detected, including amino acids, unsaturated fatty acids, carnitine, lipids, and metabolites related to the gut microbiota. Correspondingly, linoleic acid metabolism, D-glutamine and D-glutamate metabolism, glycerophospholipid metabolism, and alanine, aspartate, and glutamate metabolism were significantly altered in patients with DMD, compared with those of healthy volunteers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study demonstrated the abnormal metabolism of amino acids, energy, and lipids in patients with DMD, consistent with pathological features, such as recurrent muscle necrosis and regeneration, interstitial fibrosis, and fat replacement. Additionally, we found that metabolites of intestinal flora were disordered in DMD patients, providing support for treatment of intestinal microbia disturbance in DMD diseases. Our study provides a new research strategy for understanding the pathogenesis of DMD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02885-1","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T12:02:31Z","timestamp":1693915351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The metabolomic plasma profile of patients with Duchenne muscular dystrophy: providing new evidence for its pathogenesis"],"prefix":"10.1186","volume":"18","author":[{"given":"Huayan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2732-0154","authenticated-orcid":false,"given":"Bei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"issue":"11","key":"2885_CR1","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1007\/s00018-021-03821-x","volume":"78","author":"A Starosta","year":"2021","unstructured":"Starosta A, Konieczny P. Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy. Cell Mol Life Sci. 2021;78(11):4867\u201391.","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"2885_CR2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. The Lancet Neurol. 2018;17(3):251\u201367.","journal-title":"The Lancet Neurol"},{"issue":"10213","key":"2885_CR3","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","volume":"394","author":"E Mercuri","year":"2019","unstructured":"Mercuri E, B\u00f6nnemann CG, Muntoni F. Muscular dystrophies. Lancet. 2019;394(10213):2025\u201338.","journal-title":"Lancet"},{"issue":"4","key":"2885_CR4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/metabo8040061","volume":"8","author":"J Joseph","year":"2018","unstructured":"Joseph J, Cho DS, Doles JD. Metabolomic analyses reveal extensive progenitor cell deficiencies in a mouse model of duchenne muscular dystrophy. Metabolites. 2018;8(4):61.","journal-title":"Metabolites"},{"issue":"1","key":"2885_CR5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/s42003-022-03938-0","volume":"5","author":"DD Scripture-Adams","year":"2022","unstructured":"Scripture-Adams DD, Chesmore KN, Barth\u00e9l\u00e9my F, et al. Single nuclei transcriptomics of muscle reveals intra-muscular cell dynamics linked to dystrophin loss and rescue. Commun Biol. 2022;5(1):989.","journal-title":"Commun Biol"},{"issue":"1","key":"2885_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck N, Dan B. Pathophysiology of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol. 2007;36(1):1\u20137.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"2885_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","volume":"7","author":"D Duan","year":"2021","unstructured":"Duan D, Goemans N, Takeda S, Mercuri E, Aartsma-Rus A. Duchenne muscular dystrophy. Nat Rev Dis Primers. 2021;7(1):13.","journal-title":"Nat Rev Dis Primers"},{"key":"2885_CR8","doi-asserted-by":"crossref","first-page":"689533","DOI":"10.3389\/fcell.2021.689533","volume":"9","author":"S Yao","year":"2021","unstructured":"Yao S, Chen Z, Yu Y, et al. Current pharmacological strategies for Duchenne muscular dystrophy. Front Cell Dev Biol. 2021;9:689533.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"2885_CR9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.mehy.2015.08.015","volume":"85","author":"CA Timpani","year":"2015","unstructured":"Timpani CA, Hayes A, Rybalka E. Revisiting the dystrophin-ATP connection: how half a century of research still implicates mitochondrial dysfunction in Duchenne muscular dystrophy aetiology. Med Hypotheses. 2015;85(6):1021\u201333.","journal-title":"Med Hypotheses"},{"issue":"12","key":"2885_CR10","doi-asserted-by":"crossref","first-page":"9734","DOI":"10.3390\/nu7125498","volume":"7","author":"E Rybalka","year":"2015","unstructured":"Rybalka E, Timpani CA, Stathis CG, et al. Metabogenic and nutriceutical approaches to address energy dysregulation and skeletal muscle wasting in Duchenne muscular dystrophy. Nutrients. 2015;7(12):9734\u201367.","journal-title":"Nutrients"},{"issue":"1","key":"2885_CR11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/s41598-021-81090-1","volume":"11","author":"I Dabaj","year":"2021","unstructured":"Dabaj I, Ferey J, Marguet F, et al. Muscle metabolic remodelling patterns in Duchenne muscular dystrophy revealed by ultra-high-resolution mass spectrometry imaging. Sci Rep. 2021;11(1):1906.","journal-title":"Sci Rep"},{"key":"2885_CR12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.freeradbiomed.2018.10.404","volume":"129","author":"A Lindsay","year":"2018","unstructured":"Lindsay A, McCourt PM, Karachunski P, et al. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy. Free Radic Biol Med. 2018;129:364\u201371.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"2885_CR13","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s41598-020-57610-w","volume":"10","author":"CA Timpani","year":"2020","unstructured":"Timpani CA, Goodman CA, Stathis CG, et al. Adenylosuccinic acid therapy ameliorates murine duchenne muscular dystrophy. Sci Rep. 2020;10(1):1125.","journal-title":"Sci Rep"},{"issue":"10","key":"2885_CR14","doi-asserted-by":"crossref","first-page":"e1914171","DOI":"10.1001\/jamanetworkopen.2019.14171","volume":"2","author":"P Hafner","year":"2019","unstructured":"Hafner P, Bonati U, Klein A, et al. Effect of combination l-Citrulline and metformin treatment on motor function in patients with Duchenne muscular dystrophy: a Randomized Clinical Trial. JAMA Netw Open. 2019;2(10):e1914171.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2885_CR15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3390\/metabo12040357","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li EM, Xu LY. Guide to metabolomics analysis: a bioinformatics workflow. Metabolites. 2022;12(4):357.","journal-title":"Metabolites"},{"issue":"7","key":"2885_CR16","doi-asserted-by":"crossref","first-page":"e0159895","DOI":"10.1371\/journal.pone.0159895","volume":"11","author":"SM Boca","year":"2016","unstructured":"Boca SM, Nishida M, Harris M, et al. Discovery of metabolic biomarkers for duchenne muscular dystrophy within a natural history study. PLoS ONE. 2016;11(7):e0159895.","journal-title":"PLoS ONE"},{"issue":"3","key":"2885_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0009-8981(82)90140-1","volume":"122","author":"G Berthillier","year":"1982","unstructured":"Berthillier G, Eichenberger D, Carrier HN, et al. Carnitine metabolism in early stages of Duchenne muscular dystrophy. Clin Chim Acta. 1982;122(3):369\u201375.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2885_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41579-021-00621-9","volume":"20","author":"A Bauermeister","year":"2022","unstructured":"Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, Jarmusch AK, Dorrestein PC. Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol. 2022;20(3):143\u201360.","journal-title":"Nat Rev Microbiol"},{"key":"2885_CR19","doi-asserted-by":"crossref","first-page":"730638","DOI":"10.3389\/fonc.2021.730638","volume":"11","author":"B Xu","year":"2021","unstructured":"Xu B, Chen Y, Chen X, et al. Metabolomics profiling discriminates prostate cancer from benign prostatic hyperplasia within the prostate-specific antigen gray zone. Front Oncol. 2021;11:730638.","journal-title":"Front Oncol"},{"issue":"1","key":"2885_CR20","doi-asserted-by":"crossref","first-page":"7097","DOI":"10.1038\/s41598-018-25401-z","volume":"8","author":"T Hassanov","year":"2018","unstructured":"Hassanov T, Karunker I, Steinberg N, Erez A, Kolodkin-Gal I. Novel antibiofilm chemotherapies target nitrogen from glutamate and glutamine. Sci Rep. 2018;8(1):7097.","journal-title":"Sci Rep"},{"issue":"8","key":"2885_CR21","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.mri.2012.04.003","volume":"30","author":"AB Martins-Bach","year":"2012","unstructured":"Martins-Bach AB, Bloise AC, Vainzof M, Rahnamaye Rabbani S. Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS). Magn Reson Imaging. 2012;30(8):1167\u201376.","journal-title":"Magn Reson Imaging"},{"issue":"7835","key":"2885_CR22","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41586-020-2857-9","volume":"587","author":"M Shang","year":"2020","unstructured":"Shang M, Cappellesso F, Amorim R, et al. Macrophage-derived glutamine boosts satellite cells and muscle regeneration. Nature. 2020;587(7835):626\u201331.","journal-title":"Nature"},{"issue":"3","key":"2885_CR23","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1165\/rcmb.2017-0238OC","volume":"58","author":"J Ge","year":"2018","unstructured":"Ge J, Cui H, Xie N, et al. Glutaminolysis promotes collagen translation and stability via \u03b1-ketoglutarate-mediated mTOR activation and proline hydroxylation. Am J Respir Cell Mol Biol. 2018;58(3):378\u201390.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"2885_CR24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1165\/rcmb.2018-0180OC","volume":"60","author":"L Bai","year":"2019","unstructured":"Bai L, Bernard K, Tang X, et al. Glutaminolysis epigenetically regulates antiapoptotic gene expression in idiopathic pulmonary fibrosis fibroblasts. Am J Respir Cell Mol Biol. 2019;60(1):49\u201357.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"697","key":"2885_CR25","doi-asserted-by":"crossref","first-page":"eaay1027","DOI":"10.1126\/scisignal.aay1027","volume":"14","author":"B Selvarajah","year":"2021","unstructured":"Selvarajah B, Azuelos I, Anastasiou D, Chambers RC. Fibrometabolism-an emerging therapeutic frontier in pulmonary fibrosis. Sci Signal. 2021;14(697):eaay1027.","journal-title":"Sci Signal"},{"issue":"7835","key":"2885_CR26","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","volume":"587","author":"NC Henderson","year":"2020","unstructured":"Henderson NC, Rieder F, Wynn TA. Fibrosis: from mechanisms to medicines. Nature. 2020;587(7835):555\u201366.","journal-title":"Nature"},{"issue":"4","key":"2885_CR27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1165\/rcmb.2019-0051OC","volume":"61","author":"H Cui","year":"2019","unstructured":"Cui H, Xie N, Jiang D, et al. Inhibition of glutaminase 1 attenuates experimental pulmonary fibrosis. Am J Respir Cell Mol Biol. 2019;61(4):492\u2013500.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"2885_CR28","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"C Jang","year":"2016","unstructured":"Jang C, Oh SF, Wada S, et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat Med. 2016;22(4):421\u20136.","journal-title":"Nat Med"},{"issue":"5","key":"2885_CR29","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0306-9877(94)90112-0","volume":"43","author":"CA Bonsett","year":"1994","unstructured":"Bonsett CA, Rudman A. Oil globules\u2019 in Duchenne muscular dystrophy\u2013history, demonstration, and metabolic significance. Med Hypotheses. 1994;43(5):327\u201338.","journal-title":"Med Hypotheses"},{"issue":"3","key":"2885_CR30","doi-asserted-by":"crossref","first-page":"e0283869","DOI":"10.1371\/journal.pone.0283869","volume":"18","author":"M Signorelli","year":"2023","unstructured":"Signorelli M, Tsonaka R, Annemieke AR, et al. Multiomic characterization of disease progression in mice lacking dystrophin. PLoS ONE. 2023;18(3):e0283869.","journal-title":"PLoS ONE"},{"issue":"4","key":"2885_CR31","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S0387-7604(12)80071-4","volume":"12","author":"H Nishio","year":"1990","unstructured":"Nishio H, Wada H, Matsuo T, et al. Glucose, free fatty acid and ketone body metabolism in Duchenne muscular dystrophy. Brain Dev. 1990;12(4):390\u2013402.","journal-title":"Brain Dev"},{"issue":"9\u201310","key":"2885_CR32","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s12272-021-01352-4","volume":"44","author":"S Hwang","year":"2021","unstructured":"Hwang S, Chung kw. Targeting fatty acid metabolism for fibrotic disorders. Arch Pharm Res. 2021;44(9\u201310):839\u201356.","journal-title":"Arch Pharm Res"},{"issue":"5","key":"2885_CR33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/mus.27399","volume":"64","author":"TTJ Veeger","year":"2021","unstructured":"Veeger TTJ, van Zwet EW, Al Mohamad D, et al. Muscle architecture is associated with muscle fat replacement in Duchenne and Becker muscular dystrophies. Muscle Nerve. 2021;64(5):576\u201384.","journal-title":"Muscle Nerve"},{"issue":"2","key":"2885_CR34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0730-725X(02)00646-X","volume":"21","author":"U Sharma","year":"2003","unstructured":"Sharma U, Atri S, Sharma MC, Sarkar C, Jagannathan NR. Skeletal muscle metabolism in Duchenne muscular dystrophy (DMD): an in-vitro proton NMR spectroscopy study. Magn Reson Imaging. 2003;21(2):145\u201353.","journal-title":"Magn Reson Imaging"},{"issue":"3","key":"2885_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0022-510X(83)90027-8","volume":"59","author":"JL Podolski","year":"1983","unstructured":"Podolski JL, Lubansky HJ, Sarpel G, Danon MJ, Lazowski E, Omachi A. Erythrocyte membrane lysophospholipase activity in muscular dystrophy. J Neurol Sci. 1983;59(3):423\u20139.","journal-title":"J Neurol Sci"},{"issue":"5","key":"2885_CR36","doi-asserted-by":"crossref","first-page":"165674","DOI":"10.1016\/j.bbadis.2020.165674","volume":"1866","author":"MV Dubinin","year":"2020","unstructured":"Dubinin MV, Talanov EY, Tenkov KS, et al. Duchenne muscular dystrophy is associated with the inhibition of calcium uniport in mitochondria and an increased sensitivity of the organelles to the calcium-induced permeability transition. Biochim Biophys Acta Mol Basis Dis. 2020;1866(5):165674.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"3","key":"2885_CR37","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jcsm.12405","volume":"10","author":"MC Hughes","year":"2019","unstructured":"Hughes MC, Ramos SV, Turnbull PC, et al. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2 O2 emission during impaired oxidative phosphorylation. J Cachexia Sarcopenia Muscle. 2019;10(3):643\u201361.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"1","key":"2885_CR38","doi-asserted-by":"crossref","first-page":"15555","DOI":"10.1038\/s41598-018-33930-w","volume":"8","author":"A Kuno","year":"2018","unstructured":"Kuno A, Hosoda R, Sebori R, et al. Resveratrol ameliorates mitophagy disturbance and improves cardiac pathophysiology of dystrophin-deficient mdx mice. Sci Rep. 2018;8(1):15555.","journal-title":"Sci Rep"},{"issue":"7","key":"2885_CR39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41419-019-1767-y","volume":"10","author":"YF Lin","year":"2019","unstructured":"Lin YF, Xiao MH, Chen HX, et al. A novel mitochondrial micropeptide MPM enhances mitochondrial respiratory activity and promotes myogenic differentiation. Cell Death Dis. 2019;10(7):528.","journal-title":"Cell Death Dis"},{"issue":"4","key":"2885_CR40","doi-asserted-by":"crossref","first-page":"eabh4423","DOI":"10.1126\/sciadv.abh4423","volume":"8","author":"PP Laurila","year":"2022","unstructured":"Laurila PP, Luan P, Wohlwend M, et al. Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy. Sci Adv. 2022;8(4):eabh4423.","journal-title":"Sci Adv"},{"issue":"5","key":"2885_CR41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, et al. A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell. 2020;180(5):862\u2013877e22.","journal-title":"Cell"},{"issue":"8","key":"2885_CR42","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/biom12081120","volume":"12","author":"C Fang","year":"2022","unstructured":"Fang C, Zuo K, Jiao K, et al. PAGln, an atrial fibrillation-linked gut microbial metabolite, acts as a promoter of atrial myocyte injury. Biomolecules. 2022;12(8):1120.","journal-title":"Biomolecules"},{"issue":"11","key":"2885_CR43","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1136\/gutjnl-2020-323314","volume":"70","author":"F Brial","year":"2021","unstructured":"Brial F, Chilloux J, Nielsen T, et al. Human and preclinical studies of the host-gut microbiome co-metabolite hippurate as a marker and mediator of metabolic health. Gut. 2021;70(11):2105\u201314.","journal-title":"Gut"},{"issue":"9","key":"2885_CR44","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.stem.2022.08.008","volume":"29","author":"L Chen","year":"2022","unstructured":"Chen L, Jiao T, Liu W, et al. Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal. Cell Stem Cell. 2022;29(9):1366\u20131381e9.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2885_CR45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s10620-020-06208-3","volume":"66","author":"M Xu","year":"2021","unstructured":"Xu M, Cen M, Shen Y, et al. Deoxycholic acid-induced gut dysbiosis disrupts bile acid enterohepatic circulation and promotes intestinal inflammation. Dig Dis Sci. 2021;66(2):568\u201376.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"2885_CR46","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/07853890.2021.1900593","volume":"53","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Yu J, Li Y, et al. Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15\/19 signalling. Ann Med. 2021;53(1):508\u201322.","journal-title":"Ann Med"},{"key":"2885_CR47","doi-asserted-by":"crossref","first-page":"111630","DOI":"10.1016\/j.mad.2022.111630","volume":"202","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Yu J, Ji X, et al. Ileal FXR-FGF15\/19 signaling activation improves skeletal muscle loss in aged mice. Mech Ageing Dev. 2022;202:111630.","journal-title":"Mech Ageing Dev"},{"issue":"3","key":"2885_CR48","doi-asserted-by":"crossref","first-page":"e16225","DOI":"10.15252\/emmm.202216225","volume":"15","author":"H Kalkan","year":"2023","unstructured":"Kalkan H, Pagano E, Paris E, et al. Targeting gut dysbiosis against inflammation and impaired autophagy in Duchenne muscular dystrophy. EMBO Mol Med. 2023;15(3):e16225.","journal-title":"EMBO Mol Med"},{"issue":"3","key":"2885_CR49","doi-asserted-by":"crossref","first-page":"e16244","DOI":"10.15252\/emmm.202216244","volume":"15","author":"A Farini","year":"2023","unstructured":"Farini A, Tripodi L, Villa C, et al. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice. EMBO Mol Med. 2023;15(3):e16244.","journal-title":"EMBO Mol Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02885-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02885-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02885-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:38:02Z","timestamp":1700494682000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02885-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2885"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02885-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"18 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective study was approved by the Institutional Review Board (IRB) and completed the clinical trial registration (registration number: ChiCTR2200055651; ). The requirement for informed consent was acquired from patients\u2019 legal guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"273"}}